Evidence map›Paper›PMID 37293859›Full record

ArticleInternational journal of oncology2023

[Corrigendum] MicroRNA‑133b targets TGFβ receptor I to inhibit TGF‑β‑induced epithelial‑to‑mesenchymal transition and metastasis by suppressing the TGF‑β/SMAD pathway in breast cancer.

Shengjie Wang, Mingliang Huang, Zichen Wang, Wan Wang, Zhiyuan Zhang, Shuting Qu, Chun Liu

Open access · hybridAbstract readPublished Erratum
In one paragraph

Article in International journal of oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shengjie WangLaboratory Animal Center of Nantong University, Nantong, Jiangsu 226000, P.R. China.
Mingliang HuangMedical College of Nantong University, Nantong, Jiangsu 226000, P.R. China.
Zichen WangMedical College of Nantong University, Nantong, Jiangsu 226000, P.R. China.
Wan WangMedical College of Nantong University, Nantong, Jiangsu 226000, P.R. China.
Zhiyuan ZhangMedical College of Nantong University, Nantong, Jiangsu 226000, P.R. China.
Shuting QuMedical College of Nantong University, Nantong, Jiangsu 226000, P.R. China.
Chun LiuLaboratory Animal Center of Nantong University, Nantong, Jiangsu 226000, P.R. China.
Nantong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the publication of the above article, an interested reader drew to the authors' attention that, for the MCF‑7 cell migration assays shown in Fig. 3C on p. 1105, the representative images selected for the 'TGF‑β+ / miR‑NC' and 'TGF‑β1‑ / miR‑NC' experiments were found to be overlapping, such that the data appeared to have been derived from the same original source. After having consulted their original data, the authors noted that the error had arisen during the process of assembling this figure, and the data chosen for the 'TGF‑β+ / miR‑NC' panel had been selected incorrectly. The revised version of Fig. 3 is shown on the next page. The authors regret that these errors went unnoticed prior to the publication of this article, and thank the Editor of

Indexed as

breast cancerepithelial-to-mesenchymal transitionmetastasismicroRNA-133btransforming growth factor-β receptor Itransforming growth factor-β/SMAD pathway

Identifiers

PMID37293859
PMCPMC10308325
OpenAlexW4379514968

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.